Life ScienceCompany
KALA BIO M&A Summary
KALA BIO has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.
KALA BIO’s largest acquisition to date was in 2021, when it acquired Combangio for $16M. It’s largest disclosed sale occurred in 2022, when it sold Kala Pharmaceuticals - EYSUVIS & INVELTYS to Alcon for $60M. KALA BIO has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
KALA BIO Business Overview
Where is KALA BIO headquartered?
KALA BIO is headquartered in Arlington, Massachusetts.
What is KALA BIO’s revenue?
KALA BIO disclosed revenue of 4M USD for 2022 and 11M USD for 2021.
How many employees does KALA BIO have?
KALA BIO has 43 employees.
What sector is KALA BIO in?
KALA BIO is a life science company.
When was KALA BIO founded?
KALA BIO was founded in 2009.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1